Lorcaserin Hydrochloride

Product name  Lorcaserin Hydrochloride Other Name (R)-1H-3-BENZAZEPINE,8-CHLORO-2,3,4,5-TETRAHYDRO-1-METHYL-,HYDROCHLORIDE;LORCASERIN HCL;Lorcaserin hydrochloride;(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride;(1R)-8-chloro-1-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;R Lorcaserin hydrochloride;lorcaserin hydrochloride (APD-356);(R)-8-Chloro-1-Methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride Original China CAS 846589-98-8 Molecular formula C11H15Cl2N Brand name NJBNSteroid Leading time within 24 hours upon receipt of payment Delivery Fast and secure shipping by EMS, DHL, TNT, FedEx, UPS Purity 99% Package Discreet and Hidden package according to specific requirement Appearance White Powder Certification SGS, ISO 9001, KOSHER Payment Terms Western Union, Money Gram , T/T, Bitcoin Minimum Order Quantity 5g Price Negotiable Usage Lorcaserin is a new drug for the treatment of obesity Molecular structure

2.Key Specification Index:

Test Items Specification Test Results Description White or almost white crystalline powder White crystalline powder Melting Point 191.0~193.0ºC 192ºC Loss of drying ≤1.0% 0.5% Heavy Metal ≤20ppm 15ppm TLC Only one spot Only one spot Assay ≥99.5% 99.91% Conclusion It complies with the USP 32.    

3.Description Lorcaserin, currently marketed under the trade name Belviq and previously Lorqess during development, is a weight-loss drugdeveloped by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic.

Lorcaserin is a new drug for the treatment of obesity , belonging to oral potent selective serotonin 2C receptor agonists, lorcaserin hydrochloride is successfully developed by the US company Arena, on June 27, 2012 by the US FDA it is approved for marketing, as adjuvant therapy for obesity or merge with at least one weight-related complications in overweight adults in low-calorie diet and exercise basis .

4.Application Clinical studies show that the drug can reduce weight of obesity and overweight patients ,it can improve obesity-related metabolic parameters, and it is well tolerated. Lorcaserin affinity for the 5-HT2c 100 times higher than the 5-HT2B (valvular heart disease risk) ,it has good safety,it is the first FDA-approved weight-loss drug after 1999 .

In a year of Lorcaserin treatment, the average weight loss ranges from 3 to 3.7 percent. Safety: Lorcaserin has good tolerability and safety, lorcaserin is used in non-diabetic patients, the most common adverse reactions are headache, dizziness, fatigue, nausea, dry mouth and constipation.

This product is used in patients with diabetes, common adverse reactions are headache, back pain, cough, low blood sugar and fatigue.studies have found that lorcaserin and placebo are Similar in the proportion of serious adverse reactions,